HF Etiology and the Sustainability of Favorable Response After LVAD Weaning: A VAD Wean Registry Analysis

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:

• Consultant Fee/Honoraria/Speaker’s Bureau - Abbott
• Grant Support/Research Contract - Novartis